Roche Value Chain Analysis
Fully Editable
Tailor To Your Needs In Excel Or Sheets
Professional Design
Trusted, Industry-Standard Templates
Pre-Built
For Quick And Efficient Use
No Expertise Is Needed
Easy To Follow
Make Smarter Decisions with the Full Value Chain Report
This Roche Value Chain Analysis helps you understand how the company creates value through its support and primary activities. This page already shows a real sample of the analysis, so you can review the format and content before buying. Purchase the full version to get the complete ready-to-use report.
Support Activities
Firm Infrastructure
Roche's Basel-based dual Pharmaceuticals and Diagnostics setup gives it one clear governance layer for two tightly regulated businesses. In 2025, that structure helped align compliance, quality, and risk controls across 103,000-plus employees and operations in 100+ countries, so clinical, manufacturing, and commercial decisions stayed coordinated. Central oversight also matters for capital discipline: Roche generated CHF 60.0+ billion in annual sales in 2025, so firm infrastructure directly supports scale and regulatory control.
Human Resource Management
Roche's human resource management is built around scientists, clinicians, engineers, quality specialists, and field teams, because its work spans 2 divisions and 5 therapeutic areas. Structured hiring and training help keep rare skills aligned across medicines and diagnostics, where quality and speed both matter. This matters at Roche's global scale, with operations in more than 100 countries and a large, specialized talent base.
Technology Development
In 2025, Roche's technology development was anchored by heavy R&D across medicines, biomarkers, companion diagnostics, tissue testing, and data-led lab solutions, with R&D spending at CHF 13.2 billion in 2024 and still the core growth engine. This base shortens the path from lab work to patient use and helps Roche defend its edge in oncology, immunology, infectious diseases, ophthalmology, and neuroscience. It also supports paired drug-plus-diagnostic models, which raise adoption and make switching harder.
Procurement
Roche's procurement covers biologic raw materials, reagents, assay components, packaging, and equipment parts, so supplier control is a core quality gate. Tight qualification, audit trails, and long-term sourcing help keep traceability strong and lower the risk of shortages in pharma and diagnostics. That matters because even one weak input can disrupt regulated production and delay patient supply.
Roche's Global Support Backbone Powers Compliance, Talent, and Growth
Roche's support activities are built to keep two regulated businesses aligned. In 2025, central governance supported 103,000+ employees across 100+ countries and CHF 60 billion+ sales, so compliance and risk control stayed tight.
HR keeps scarce scientific and quality talent in place. Technology and procurement back Roche's drug-diagnostic model with heavy R&D and strict supplier controls.
| Support | 2025 data |
|---|---|
| Scale | 103,000+ employees |
| Reach | 100+ countries |
| Sales | CHF 60 billion+ |
What is included in the product
Detailed Word Document
Editable Excel File
Primary Activities
Inbound Logistics
Roche's inbound logistics relies on tightly controlled flows of active ingredients, biologic materials, lab reagents, device parts, and packaging, with temperature control, lot traceability, and incoming quality checks protecting batch integrity. Roche operated in 100+ countries and spent CHF 13.0 billion on R&D in 2024, which shows how critical supplier quality is before materials reach manufacturing or diagnostics assembly. This setup reduces contamination risk, supports compliance, and keeps release times tight.
Operations
Roche's Operations turn scientific research into medicines and diagnostics, with GMP manufacturing, quality control, and regulatory release keeping pharma and diagnostics performance consistent. In 2025, Roche reported CHF 60.5 billion in Group sales and invested CHF 13.0 billion in R&D, so operational control directly supports scale, compliance, and product launch speed across its portfolio.
Outbound Logistics
Roche's outbound logistics moves prescription medicines, diagnostics systems, reagents, and service parts through global healthcare channels in more than 100 countries. Cold-chain transport, regional warehousing, and scheduled replenishment help keep temperature-sensitive products usable when they reach hospitals, labs, and distributors. In 2025, that scale supported a business that generated about CHF 60 billion in annual sales, so delivery speed and condition control directly protect revenue and patient access.
Marketing and Sales
In 2025, Roche sold through specialized healthcare teams, medical affairs, tenders, and account-based selling to hospitals, labs, payers, and physicians. Demand creation came from clinical data, reimbursement access, and product training, not mass consumer ads. That makes sales execution tied to evidence and access wins, not just promotion.
Service
In 2025, Roche's service work covers technical troubleshooting, assay validation, instrument maintenance, medical information, and pharmacovigilance, helping labs and clinicians keep diagnostics and therapies running with fewer disruptions. This after-sale support is critical because Roche's platforms often stay in use for years and need ongoing performance checks, safety monitoring, and fast issue resolution across the treatment cycle.
Roche Turns Science Into Global Sales
Roche's primary activities turn science into medicines and diagnostics through controlled sourcing, GMP manufacturing, evidence-led sales, and long-term service across 100+ countries. In 2025, Group sales were CHF 60.5 billion and R&D spend was CHF 13.0 billion, so quality, speed, and access shape revenue. After-sale support for assays, instruments, and safety monitoring helps keep products in use and protects clinical trust.
| Metric | 2025 |
|---|---|
| Group sales | CHF 60.5 billion |
| R&D spend | CHF 13.0 billion |
Full Version Awaits
Roche Reference Sources
This is the actual Roche Value Chain Analysis document you'll receive upon purchase – no surprises, just professional quality. The preview below is taken directly from the full report, so what you see here is what you get. Purchase unlocks the complete, detailed version immediately.
Frequently Asked Questions
Roche combines 2 major divisions: Pharmaceuticals and Diagnostics. That integrated model links 5 therapeutic areas on the drug side with 3 diagnostics solution areas: in-vitro diagnostics, tissue-based cancer diagnostics, and integrated diabetes management solutions. The result is a chain that can support screening, diagnosis, treatment, and monitoring in one healthcare ecosystem.
Disclaimer
All information, articles, and product details provided on this website are for general informational and educational purposes only. We do not claim any ownership over, nor do we intend to infringe upon, any trademarks, copyrights, logos, brand names, or other intellectual property mentioned or depicted on this site. Such intellectual property remains the property of its respective owners, and any references here are made solely for identification or informational purposes, without implying any affiliation, endorsement, or partnership.
We make no representations or warranties, express or implied, regarding the accuracy, completeness, or suitability of any content or products presented. Nothing on this website should be construed as legal, tax, investment, financial, medical, or other professional advice. In addition, no part of this site - including articles or product references - constitutes a solicitation, recommendation, endorsement, advertisement, or offer to buy or sell any securities, franchises, or other financial instruments, particularly in jurisdictions where such activity would be unlawful.
All content is of a general nature and may not address the specific circumstances of any individual or entity. It is not a substitute for professional advice or services. Any actions you take based on the information provided here are strictly at your own risk. You accept full responsibility for any decisions or outcomes arising from your use of this website and agree to release us from any liability in connection with your use of, or reliance upon, the content or products found herein.